Doxycycline shows promise in reducing deaths and seizures from nodding syndrome

FHS
June 8, 2024
11:47 am

A new study suggests that a course of the drug doxycycline can decrease acute seizure-related hospitalization and deaths related to nodding syndrome.

GSK’s newest social media campaign offers ‘reality check’ for lupus patients

GSK wants people living with lupus to be aware of the silent danger of organ damage. Its latest social media campaign aims not only to

July 14, 2023

Pomelo Care Acquires The Doula Network to Offer Virtual & In-Person Care

What You Should Know: – Pomelo Care, a provider of evidence-based maternity care, has acquired The Doula Network, the largest network of credentialed, in-network doulas

September 25, 2024

LightOx Accelerate R&D using A4I – Lifescience Industry News

LightOx, based in Newcastle, has developed a UK-first solution for early-stage mouth cancers using light-activated chemotherapy. The treatment involves a gel being applied to the

July 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.